There's an enormous amount of literature and commentary out there about the tendency for federal regulators in general, and the FDA especially, to minimize "Typ

There's an enormous amount of literature and commentary out there about the tendency for federal regulators in general, and the FDA especially, to minimize "Type I" error (approving drugs that are unsafe/ineffective) with the negative consequence of making more "Type II" errors (not approving drugs that are safe and effective).